Philip Morris
Little Black Box of Cetus
Fields
- Author
- Allen, S.P.
- Type
- NEWS, NEWSPAPER ARTICLE
- Area
- WAKEHAM,HELMUT/KAROL SHARPE'S OFFICE
- Site
- R37
- Named Organization
- Blythe, Eastman Dillon
- Eastman Dillion
- Fortune Magazine
- Standford
- Uc-Berkeley
- Upjohn
- Zoecon
- Ae Pointing
- Eastman Dillion
- Named Person
- Cape, R.
- Djerassi, C.
- Farley, P.
- Glaser, D.A.
- Lederberg, J.
- Ward, C.
- Zaffaroni, A.
- Djerassi, C.
- Request
- Stmn/R1-004
- Stmn/R1-150
- Author (Organization)
- San Francisco Chronicle
- Master ID
- 1000229536/9811
Related Documents:- 1000229537-9544
- 1000229545-9550 Brief Synopsis
- 1000229551-9552 Introduction
- 1000229553-9555 Brief History of Cetus Financing
- 1000229556-9557
- 1000229558-9560 Special Note to Investors
- 1000229561-9563 Special Note Regarding Founder's Stock
- 1000229567-9569 Board of Directors
- 1000229575-9580 Achievements of Cetus People
- 1000229581-9599 Present Cetus Activities
- 1000229600-9616 Research Plan
- 1000229617-9619 Patents
- 1000229621-9656 Debenture Purchase Agreement
- 1000229657-9661 the Cetus Story
- 1000229663-9667 Cloning Business: It's Growing Fast It's Growing Fast
- 1000229668 World Roundup
- 1000229669-9670 Latin Drive: Brazil Spends Millions to Put Alcohol in Cars and Save Oil
- 1000229671 Can US Reduce Imports with Gasoline? Some Say Yes, But Officials Are Dubious
- 1000229672-9673 Bacterial Insulin Production Hears Reality
- 1000229674 Business World
- 1000229675-9677 Who Should Play God?
- 1000229678 Schering Plough New York Analysts' Meeting December 7, 1977
- 1000229679 Indiana Standard Labels Purchase Offer Part of Move to Wider Technology Base
- 1000229680 Big Deal for Berkley Bugs
- 1000229681 Oil-Less World May Run on Bugs
- 1000229682-9685 Tinkering with Life
- 1000229686-9687 Set for Biology's New Revolution
- 1000229689-9695 Industry Is Finding More Jobs for Microbes
- 1000229696-9701 Dup of Id 1000229657-9661
- 1000229702-9710 Recombinant Molecular Research at Cetus Corporation
- 1000229711-9715 New Cetus Antibiotic
- 1000229716-9720 Letter to the Shareholders
- 1000229721-9726 Letter to Shareholders
- 1000229727-9728 Letters to the Shareholders
- 1000229729-9730
- 1000229731-9734 Letter to the Shareholders
- 1000229735-9736 Letter to Shareholders
- 1000229737-9749 the Manipulation of Genes
- 1000229750-9770 Microbial Genetics and the Future of the Pharmaceutical Industry
- 1000229771-9774 Recombinant Dna: Fact and Fiction
- 1000229775-9778 Testomony of Ronald E Cape, Phd President, Cetus Corporation, Berkeley, California Before the House Subcommittee on Science, Research and Technology
- 1000229779-9797 Biosystems Poised for Growth
- 1000229798-9805 Testimony of Ronald E. Cape, Ph.D President, Cetus Corporation, Berkley, California Before the Senate Subcommittee on Science, Technology and Space
- 1000229806-9807 Statement of Ronald E. Cape, Ph.D President, Cetus Corporation, Berkeley, California Before A Special Joint Congressional Hearing in Conjunction with Oversight Hearings on Science and Technology Policy the Senate Subcommittee on Science, Technology and Space of the Commerce, Science and Transportation Committee Presiding, Senator Adlai Stevenson, III Washington, Dc
- 1000229808-9811 Statement of Ronald E. Cape, Ph.D. President, Cetus Corporation, Berkeley, California at the Annual Meeting of the American Association for the Advancement of Science Session on Recombinant Dna Public Health and Biomedical Research Policy Washington, D.C.
- Litigation
- Stmn/Produced
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- lei84e00
Document Images
By Sidney P. Allen
Financial Editor
TUESDAY, FEBRUARY 12, 1974 48
tN C?l~E YOU ha~-e been rendered a mite cu-
ious as the name Cetus has echoed from the hills of
rkeiey to San Francisco's salons of ° high finance
4.nd on dov'rt to Stanford and Silicon Valley arenas, ihw
shrouds of niystery hare now lii'tNCi.
The Iate:i issue of Forttin(11r~,azi~rr litied'th~
veil.
And nowDr. Peter Farley a founder and' rice
president of Cetus, agrees it's time to tell the u orlci
about the Young Berkeley - based company.
got off the ground about 21, years dgo, pro-
pelled by a founding group of five scientifically orient-
ed men. The group: Dr. Farley, a physician and man-
agement consultant to venture capitalists; his asso-
eiate Ron Cape; professor Donald A. Glaser of UC-
Berkeley, biologist; Dr. Calvin Ward, an associate of
xlaser; 11oshP alafi. bio-physiiisi and venture capita-
9ist.
' lt has been financed to the tune of some S5 niil-
lion, %ia private placements mostly arranged by A.E.
Pouting of Blythe, Eastman Dillon & Co. It has a
score or so of "oivners:"
And, albng with its founders. it boasts some of the
top nanies of science in the world. These incltade Stan-
ford's Nobel prize geneticist Joshue Lederberg. (Glas-
er is also a Nobel prize winner. ) Carl Djerassi and
"'Pjandro Zaffaroni, chief execiitivN: of Zoecon ('oirp.
Ci- 9 .alza Corqj: respecth-ely.
That isn't all. But obviously it makes the point
that Cetus surely has got the attentiun of r.uilcin.- e-N-
pert% in tlte world of'biolot;iucl science.
TS PLACE in the sun. as 17r. Farley exp latns the
Cetus activities. is that it ha- devised the scientiti.
1.ools and developed' a systeat t o'a ut ioma t c the step in
--
"
:miei~~uhio.lo;ieal re~earch.
If that sounds simple enough. what it means Is'
rhati Cetus can gteatly, accelerate the pruaess. be it a;~
; quest for neir antibiotics or a quest for inlpro~-ing the
} ield of antibiotic producing bugs. 2.
The name of the game in such research, explained
Dr. Farley, is numbers, or spinning the wheel taster,
And to give an idea of the Cett>rs csipa.bilit~y:
"We could now repeat iit two years evei~-thinc
done by the phainnaceutical'industry in aU year
Cetus can do this in its "little black bos"-
a
;
:
;
._~
building-size laboraroory of incubators, feeding con,.
partments. analysis chambers. and batteiries of technr- 1"
cal instruments. It's all prn!_-rammFr)1,\ ,rtmip»rerr anrl ~~
analyzed by computer.
- -,, ..;.
The little blacl: box is. of course, the Cetus secret.
Patents on instrunuent'4 and system are on applicatinn. ;
~ * *
W HEN RESEARCH that might take a good phar-
maceutical company 10 years to accomplish can
he telescoped into one year. clearlv it's replete uith
dazzling commercial as wellias scientific applications.
So the; pharmaceutical doers of the world are
cuming to Berkeley in a steady stream now.
That's the word.
A couple of pharmaceutical' contracts (one with
L'ohn are now in the Cetus house. and'others are
just around the corner.
~ ~ .
"
Vithout any hu`e frontend capitalot
V- cs. we can
take a major role in~the microhiologiral research for
the whole pharmaceutical industrn-," says Dr. Farle.:
That's done ocrcc+nt r:wt
And if and when the Cetu, %tiork le.'tds to better
ne'<<v antibiotic products. it can cut in -, ia royalties.
..XVe have the physmill machinetx .,w": And ti'e
ha\c° the t~NSt reHm of inrdrrstrial _,enotickts any-
wher°e,"
"i\'e think CetuI: ii- to inducrrirl intcrnk~iolu;± a-Z
the car!y comptrte.r was IC) 'iiAta proces~i+r_: ..
* * *
